Table 3 Univariate and multivariate analysis for risk factors for EFS

From: Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

Valuables

Univariate analysis

Multivariate analysis

p-Value

Hazard ratio

p-Value

Disease status

0.724

–

–

Treatment center

0.411

–

–

Cycles of chemotherapy

0.608

–

–

Donor type

0.122

–

–

Bone marrow blast

0.070

6.679 (1.381, 32.305)

0.018

Age

0.143

1.036 (1.003, 1.069)

0.031

Back to article page